Fidelity Investments
TLX

Fidelity Investments’s Telix Pharmaceuticals TLX Stock Holding History

Fidelity Investments’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.47M Sell
561,206
-3,551
-0.6% -$36.2K ﹤0.01% 2326
2026
Q1 		$5.4M Buy
564,757
+441,187
+357% +$3.36M ﹤0.01% 2278
2025
Q4 		$926K Buy
123,570
+5,091
+4% +$49K ﹤0.01% 2873
2025
Q3 		$1.13M Buy
118,479
+76,388
+181% +$936K ﹤0.01% 2753
2025
Q2 		$681K Buy
+42,091
New +$707K ﹤0.01% 2861

Other funds holding TLX

Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Fidelity Investments's TLX Position: Q2 2026 in Review

Fidelity Investments reduced its Telix Pharmaceuticals (TLX) stake by 0.63% in Q2 2026, selling an estimated $36.2K and leaving 561,206 shares worth $6.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2326.

Fidelity Investments first reported a position in TLX in Q2 2025 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

  • Fidelity Investments held 561,206 shares of Telix Pharmaceuticals worth $6.47M as of Q2 2026.
  • Fidelity Investments sold 3,551 Telix Pharmaceuticals shares in Q2 2026, an estimated $36.2K.
  • Telix Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2326 holding.
  • Fidelity Investments first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 61 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.